An open-label trial of donepezil in vascular and mixed dementia.
Phase of Trial: Phase III
Latest Information Update: 26 Mar 2015
At a glance
- Drugs Donepezil (Primary)
- Indications Dementia; Vascular dementia
- Focus Therapeutic Use
- Acronyms Vaspect
- Sponsors Pfizer
- 31 Aug 2018 Biomarkers information updated
- 12 Nov 2008 Status changed from completed to discontinued, as reported in ClinicalTrials.Gov record. The trial was terminated on 15 Oct 2007 citing recruitment difficulties and emphasising no safety or efficacy concerns regarding the study medication.
- 25 Sep 2008 Actual patient number (149) added as reported by ClinicalTrials.gov.